Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 6/20 | 1.00 |
| ▸ | CYP1B1 | Q16678 | 6/20 | 1.00 |
| ▸ | PTGS2 | P35354 | 5/20 | 1.00 |
| ▸ | ALOX5 | P09917 | 5/20 | 1.00 |
| ▸ | TTR | P02766 | 4/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.89 |
| ▸ | NQO2 | P16083 | 5/20 | 0.89 |
| ▸ | MEN1 | O00255 | 4/20 | 0.89 |
| ▸ | MAPT | P10636 | 4/20 | 0.89 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.89 |
| ▸ | ABL1 | P00519 | 4/20 | 0.89 |
| ▸ | BCR | P11274 | 4/20 | 0.89 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.89 |
| ▸ | ABCB1 | P08183 | 3/20 | 0.89 |
| ▸ | NPC1 | O15118 | 2/20 | 0.89 |
| ▸ | GAA | P10253 | 2/20 | 0.89 |
| ▸ | RAB9A | P51151 | 2/20 | 0.89 |
| ▸ | GFER | P55789 | 2/20 | 0.89 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.89 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.89 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30475363 | 1.00 | CYP1A1 (1.00) | CYP1A1CYP1B1PTGS2ALOX5TTR | |
| SCHEMBL562335 | 1.00 | CYP1A1 (1.00) | CYP1A1CYP1B1PTGS2ALOX5TTR | |
| Pterostilbene SCHEMBL563218 | 0.94 | CYP1A1 (1.00) | CYP1A1CYP1B1PTGS2ALOX5TTR | |
| Pterostilbene SCHEMBL28222684 | 0.94 | CYP1A1 (1.00) | CYP1A1CYP1B1PTGS2ALOX5TTR | |
| Pterostilbene SCHEMBL3545782 | 0.94 | CYP1A1 (1.00) | CYP1A1CYP1B1PTGS2ALOX5TTR | |
| Pterostilbene SCHEMBL20063 | 0.94 | CYP1A1 (1.00) | CYP1A1CYP1B1PTGS2ALOX5TTR | |
| SCHEMBL2516449 | 0.92 | PTGS2 (0.86) | CYP1A1CYP1B1PTGS2ALOX5TTR | |
| SCHEMBL2516446 | 0.92 | PTGS2 (0.86) | CYP1A1CYP1B1PTGS2ALOX5TTR | |
| SCHEMBL29652111 | 0.92 | PTGS2 (0.86) | CYP1A1CYP1B1PTGS2ALOX5TTR | |
| SCHEMBL29662231 | 0.92 | PTGS2 (0.86) | CYP1A1CYP1B1PTGS2ALOX5TTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170087116-A1 | Treatment of Inflammatory and Infectious Skin Disorders | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2017-03-30 | — | — | US | claimed |
| US-20140018437-A1 | TREATMENT OF INFLAMMATORY AND INFECTIOUS SKIN DISORDERS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-01-16 | — | — | US | claimed |
| WO-2012129499-A1 | TREATMENT OF INFLAMMATORY AND INFECTIOUS SKIN DISORDERS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-09-27 | — | — | WO | claimed |
| US-20120178704-A1 | PREVENTION AND TREATMENT OF COLON CANCER | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY | 2012-07-12 | — | — | US | claimed |
| WO-2008070872-A1 | PREVENTION AND TREATMENT OF COLON CANCER | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2008-06-12 | — | — | WO | claimed |
| EP-4743071-A2 | DIPHENYLETHYLENE COMPOUNDS AND COMPOSITIONS THEREOF | INNOVENE INC. (US) | 2026-05-20 | — | — | EP | disclosed |
| WO-2025015023-A2 | DIPHENYLETHYLENE COMPOUNDS AND COMPOSITIONS THEREOF | INNOVENE, INC. (US) | 2025-01-16 | — | — | WO | disclosed |
| WO-2024189607-A1 | METHODS AND BIOAVAILABLE HIGHLY PERMEABLE COMPOUNDS FOR DISEASES TREATMENT | DIDENKO KIRILL (MX) | 2024-09-19 | — | — | WO | disclosed |
| CN-116637102-B | Application of flavane compound in preparation of antitumor drugs | 北京中医药大学 | 2024-04-09 | — | — | CN | disclosed |
| US-20230321002-A1 | ANTICOCCIDIAL COMPOSITION COMPRISING STILBENE-BASED COMPOUND, AND USE THEREOF | CJ CHEILJEDANG CORPORATION (KR) | 2023-10-12 | — | — | US | disclosed |
| CN-116637102-A | Application of flavane compound in preparation of antitumor drugs | 北京中医药大学 | 2023-08-25 | — | — | CN | disclosed |
| EP-4218419-A1 | ANTICOCCIDIAL COMPOSITION COMPRISING STILBENE-BASED COMPOUND, AND USE THEREOF | CJ Cheiljedang Corporation (KR) | 2023-08-02 | — | — | EP | disclosed |
| US-20090047309-A1 | COSMETIC METHODS AND COMPOSITIONS FOR REPAIRING HUMAN SKIN | ELC MANAGEMENT LLC | 2009-02-19 | — | — | US | disclosed |
| US-20090035243-A1 | Anhydrous Cosmetic Compositions Containing Resveratrol Derivatives | ELC MANAGEMENT LLC | 2009-02-05 | — | — | US | disclosed |
| US-20090035240-A1 | Aqueous Based Cosmetic Compositions Containing Resveratrol Derivatives And An Aqueous Phase Structuring Agent | ELC MANAGEMENT LLC | 2009-02-05 | — | — | US | disclosed |
| US-20090035242-A1 | Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And Linear Or Branched Silicone | ELC MANAGEMENT LLC | 2009-02-05 | — | — | US | disclosed |
| US-20090035236-A1 | Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And An Oil Phase Structuring Agent | ELC MANAGEMENT LLC | 2009-02-05 | — | — | US | disclosed |
| US-20090035237-A1 | Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And Silicone Surfactant | ELC MANAGEMENT LLC | 2009-02-05 | — | — | US | disclosed |
| WO-2008070872-A1 | PREVENTION AND TREATMENT OF COLON CANCER | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2008-06-12 | — | — | WO | disclosed |
| US-20050038125-A1 | Method for the treatment of arthritis and pain | N.V. NUTRICIA (NL) | 2005-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090035243-A1 | Anhydrous Cosmetic Compositions Containing Resveratrol Derivatives | RB1, SIRT1, EP300 | CYP1A1 1440/4885CYP1B1 902/4885PTGS2 3838/4885 |
| US-20090035242-A1 | Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And Linear Or Branched Silicone | SQLE, SMURF1, PIK3R1 | CYP1A1 2625/4885CYP1B1 1478/4885PTGS2 3228/4885 |
| US-20090047309-A1 | COSMETIC METHODS AND COMPOSITIONS FOR REPAIRING HUMAN SKIN | CUTA, ERCC1, OGG1 | CYP1A1 253/4885CYP1B1 269/4885PTGS2 3235/4885 |
| US-20120178704-A1 | PREVENTION AND TREATMENT OF COLON CANCER | APC, SI, NFKBIA | CYP1A1 1123/4885CYP1B1 1133/4885PTGS2 28/4885 |
| US-20090035237-A1 | Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And Silicone Surfactant | SMURF1, CUTA, SMURF2 | CYP1A1 2419/4885CYP1B1 2175/4885PTGS2 3901/4885 |
| US-20090035236-A1 | Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And An Oil Phase Structuring Agent | CUTA, LRAT, RARA | CYP1A1 1737/4885CYP1B1 1935/4885PTGS2 2396/4885 |
| US-20090035240-A1 | Aqueous Based Cosmetic Compositions Containing Resveratrol Derivatives And An Aqueous Phase Structuring Agent | SMARCC1, RARG, RARA | CYP1A1 1950/4885CYP1B1 1679/4885PTGS2 3031/4885 |
| US-20230321002-A1 | ANTICOCCIDIAL COMPOSITION COMPRISING STILBENE-BASED COMPOUND, AND USE THEREOF | VIP, NFATC1, CASP3 | CYP1A1 4700/4885CYP1B1 4437/4885PTGS2 2020/4885 |
| US-20050038125-A1 | Method for the treatment of arthritis and pain | LTB4R2, LTB4R, LTC4S | CYP1A1 400/4885CYP1B1 235/4885PTGS2 15/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.